Key Insights

Highlights

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02399527Recruiting

Lymphatic Anomalies Registry for the Assessment of Outcome Data

Showing all 1 trials

Research Network

Active Sponsors

  • Lymphatic Malformation Institute1
  • Boston Children's Hospital1

Top Investigators

Related Conditions

  • Blue Rubber Bleb Nevus Syndrome1
  • Lymphangiomatosis1
  • Generalized Lymphatic Anomaly Gla1
  • Lymphatic Malformation1
  • Kaposiform Lymphangiomatosis1

Activity Timeline